Vertex Pharmaceuticals (VRTX) affiliate reports multiple share sales, proceeds listed
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
VRTX reported proposed sales and recent dispositions in a Form 144 submission. The filing lists two restricted stock vesting events (1,020 shares on 02/17/2026 and 954 shares on 02/24/2026) and four reported sales by Carmen R. Bozic between 03/13/2026 and 05/15/2026.
Positive
- None.
Negative
- None.
Key Figures
Restricted stock vesting: 1,020 shares
Restricted stock vesting: 954 shares
Sale: 2,329 shares
+3 more
6 metrics
Restricted stock vesting
1,020 shares
vested on 02/17/2026 (compensation)
Restricted stock vesting
954 shares
vested on 02/24/2026 (compensation)
Sale
2,329 shares
sold on 03/13/2026 for $1,122,088.91
Sale
2,329 shares
sold on 03/27/2026 for $1,050,262.55
Sale
6,988 shares
sold on 05/12/2026 for $3,144,600.00
Sale
1,354 shares
sold on 05/15/2026 for $613,971.30
Key Terms
Rule 144 / Form 144, Restricted Stock Vesting, Issuer
3 terms
Rule 144 / Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Restricted Stock Vesting financial
"Common | 02/17/2026 | Restricted Stock Vesting"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Issuer regulatory
"Restricted Stock Vesting | Issuer | | | 1020"
FAQ
What does VRTX's Form 144 disclose about recent sales?
The filing discloses four dispositions by Carmen R. Bozic between 03/13/2026 and 05/15/2026. These include specific share counts and proceeds for each trade, listed individually in the submission.
What were the proceeds reported for the largest sale listed in the filing?
The largest reported proceeds were $3,144,600.00 from a sale of 6,988 shares on 05/12/2026. Each sale shows share count, date, and gross proceeds in the submission.
Who is the reporting person in the Form 144 and what address is listed?
The filing shows Carmen R. Bozic as the reporting person with an address at 50 Northern Avenue, Boston MA 02210. That name is tied to the four sales detailed in the form.